Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

MKSAP: 25-year-old man with abnormal liver chemistry tests

mksap
Conditions
November 4, 2012
Share
Tweet
Share

Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians.

A 25-year-old man is evaluated after being turned down as a blood donor because of abnormal liver chemistry tests. The patient is healthy, takes no medications, does not smoke, and drinks alcohol socially. His parents and siblings are alive and healthy; his maternal grandfather developed type 2 diabetes mellitus at age 75 years. The review of systems is normal.

On physical examination, vital signs and BMI are normal.

Laboratory studies:

Hemoglobin 11.9 g/dL (119 g/L)
Mean corpuscular volume 76 fL
Cholesterol (total) 155 mg/dL (4.01 mmol/L)
LDL cholesterol 85 mg/dL (2.2 mmol/L)
HDL cholesterol 33 mg/dL (0.85 mmol/L)
Bilirubin (total) 0.5 mg/dL (8.55 µmol/L)
Aspartate aminotransferase 25 U/L
Alanine aminotransferase 58 U/L
Alkaline phosphatase 110 U/L

Serologic tests for hepatitis virus infection are normal.

Which of the following is the most appropriate diagnostic test for this patient?

A) Anti-tissue transglutaminase antibody
B) α1-Antitrypsin concentration
C) Blood alcohol level
D) Liver biopsy

MKSAP Answer and Critique

The correct answer is A) Anti-tissue transglutaminase antibody. This item is available to MKSAP 15 subscribers as item 45 in the Gastroenterology section.

MKSAP 16 released Part A on July 31. More information is available online.

Celiac disease is a small-bowel disorder characterized by mucosal inflammation, villous atrophy, and crypt hyperplasia, which occur on exposure to gluten. The disease is rather common, affecting nearly 1% (1/133 persons) of the population. Although many affected patients have diarrhea and steatorrhea, as well as bloating, abdominal pain, and malabsorption of vitamins and minerals, other patients are asymptomatic at diagnosis. Such patients may be found to have anemia or osteoporosis as part of routine health maintenance testing. Still others present with neurologic symptoms, dermatitis herpetiformis, or elevated concentrations of liver enzymes. The elevated alanine aminotransferase in this patient should normalize with a gluten-free diet if he has celiac disease. The patient’s elevated alkaline phosphatase concentration is likely the result of increased bone turnover as a result of vitamin D and calcium malabsorption. Celiac disease is one of the most common causes of osteoporosis in men. Measurement of serum anti-tissue transglutaminase antibodies has a sensitivity and specificity of approximately 90% for celiac disease.

α1-Antitrypsin deficiency affects approximately 1 in 1600 persons, and although measurement of α1-antitrypsin is an appropriate test in the work-up of abnormal liver function tests, it is not the next best test because of the low prevalence of the disease compared to celiac disease, and it cannot explain the patient’s anemia. The patient admits to social use of alcohol, and this is to be strictly avoided in the setting of liver disease. Unless the patient was actively drinking alcohol around the time of the testing, measuring the blood alcohol would not be helpful. Furthermore, in alcoholic liver disease, the aspartate aminotransferase concentration is usually greater than the alanine aminotransferase. Liver biopsy would be an extreme measure to take as a result of a mildly abnormal set of liver chemistry tests and is not indicated as an initial step.

Key Point

  • Measurement of serum anti-tissue transglutaminase antibodies has a sensitivity and specificity of approximately 90% for celiac disease.

Learn more about ACP’s MKSAP 16.

This content is excerpted from MKSAP 15 with permission from the American College of Physicians (ACP). Use is restricted in the same manner as that defined in the MKSAP 15 Digital license agreement. This material should never be used as a substitute for clinical judgment and does not represent an official position of ACP. All content is licensed to KevinMD.com on an “AS IS” basis without any warranty of any nature. The publisher, ACP, shall not be liable for any damage or loss of any kind arising out of or resulting from use of content, regardless of whether such liability is based in tort, contract or otherwise.

Prev

Hearing loss is an invisible handicap

November 3, 2012 Kevin 3
…
Next

Does Oregon have the answer to rational rationing?

November 4, 2012 Kevin 11
…

ADVERTISEMENT

Tagged as: Gastroenterology

Post navigation

< Previous Post
Hearing loss is an invisible handicap
Next Post >
Does Oregon have the answer to rational rationing?

ADVERTISEMENT

More by mksap

  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 26-year-old man with back pain

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 36-year-old man with abdominal cramping, diarrhea, malaise, and nausea

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 52-year-old woman with osteoarthritis of the right hip

    mksap

More in Conditions

  • The high cost of PCSK9 inhibitors like Repatha

    Larry Kaskel, MD
  • Why non-work stress fuels burnout

    Perrette St. Preux, RN, MScPH
  • Why wellness programs fail health care

    Jodie Green & Kim Downey, PT
  • Treating chronic pain in older adults

    Claude E. Lett III, PA-C
  • A nurse’s story of hospital bullying

    Debbie Moore-Black, RN
  • Pancreatic cancer racial disparities

    Earl Stewart, Jr., MD
  • Most Popular

  • Past Week

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • Diagnosing the epidemic of U.S. violence

      Brian Lynch, MD | Physician
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
    • The physician mental health crisis in the ER

      Ronke Lawal | Policy
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The measure of a doctor, the misery of a patient

      Anonymous | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
  • Recent Posts

    • The physician mental health crisis in the ER

      Ronke Lawal | Policy
    • Is mental illness the root of mass shootings?

      Sabooh S. Mubbashar, MD | Physician
    • How new physicians can build their career

      David B. Mandell, JD, MBA | Finance
    • Moral distress vs. burnout in medicine

      Sami Sinada, MD | Physician
    • Why doctors make bad financial decisions

      Wesley J. McBride, MD, CFP | Finance
    • Is your medical career a golden cage?

      Tracy Gapin | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • Diagnosing the epidemic of U.S. violence

      Brian Lynch, MD | Physician
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
    • The physician mental health crisis in the ER

      Ronke Lawal | Policy
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The measure of a doctor, the misery of a patient

      Anonymous | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
  • Recent Posts

    • The physician mental health crisis in the ER

      Ronke Lawal | Policy
    • Is mental illness the root of mass shootings?

      Sabooh S. Mubbashar, MD | Physician
    • How new physicians can build their career

      David B. Mandell, JD, MBA | Finance
    • Moral distress vs. burnout in medicine

      Sami Sinada, MD | Physician
    • Why doctors make bad financial decisions

      Wesley J. McBride, MD, CFP | Finance
    • Is your medical career a golden cage?

      Tracy Gapin | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...